STT3A

Chr 11ADAR

STT3 oligosaccharyltransferase complex catalytic subunit A

Also known as: CDG1WAD, CDG1WAR, ITM1, STT3-A, TMC

The protein encoded by this gene is a catalytic subunit of the N-oligosaccharyltransferase (OST) complex, which functions in the endoplasmic reticulum to transfer glycan chains to asparagine residues of target proteins. A separate complex containing a similar catalytic subunit with an overlapping function also exists. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]

OMIMResearchGenerating clinical summary…
DNmechanismAD/ARLOEUF 0.492 OMIM phenotypes
Clinical SummarySTT3A
🧬
Gene-Disease Validity (ClinGen)
STT3A-congenital disorder of glycosylation · ARModerate

Moderate evidence — consider for supplementary testing

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.31) despite low pLI — interpret in context.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 107 VUS of 288 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.49LOEUF
pLI 0.002
Z-score 4.18
OE 0.31 (0.200.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.62Z-score
OE missense 0.50 (0.440.56)
205 obs / 411.7 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.31 (0.200.49)
00.351.4
Missense OE?0.50 (0.440.56)
00.61.4
Synonymous OE?0.85
01.21.6
LoF obs/exp: 13 / 42.3Missense obs/exp: 205 / 411.7Syn Z: 1.42
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongSTT3A-related type I congenital disorder of glycosylation with neuromusculoskeletal diseaseOTHERAD
limitedSTT3A-related congenital disorder of glycosylationOTHERAR

This gene — mechanism propensity

DN
0.75top 25%
GOF
0.6345th %ile
LOF
0.2872th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

288 submitted variants in ClinVar

Classification Summary

Likely Pathogenic6
VUS107
Likely Benign83
Benign62
Conflicting1
6
Likely Pathogenic
107
VUS
83
Likely Benign
62
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
6
0
0
6
VUS
3
96
6
2
107
Likely Benign
0
0
47
36
83
Benign
0
0
56
6
62
Conflicting
1
Total310210944259

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

63 pathogenic / likely-pathogenic (of 69) ClinVar copy-number / structural variants overlap STT3A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

STT3A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →